FluBlok, a next generation influenza vaccine manufactured in insect cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biologicals (Print)

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biologicals.2009.02.014PMID 19297194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Insect Viruses

  2012cited by this paper
• WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.

  2008cited by this paper
• Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization--a case study.

  2008cited by this paper
• FluBlok, a recombinant hemagglutinin influenza vaccine

  2008cited by this paper
• FluBlok, a recombinant influenza vaccine.

  2008cited by this paper
• Development of a novel recombinant influenza vaccine in insect cells.

  2008cited by this paper
• Production of a novel influenza vaccine using insect cells: protection against drifted strains

  2007cited by this paper
• Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.

  2007cited by this paper
• Latent Infection of a New Alphanodavirus in an Insect Cell Line

  2007cited by this paper
• Molecular methods for virus discovery.

  2006cited by this paper
• Detection of adventitious viruses in biologicals--a rare occurrence.

  2006cited by this paper
• Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.

  2006cited by this paper
• Detection of adventitious viruses in biologicals--a rare occurrence.

  2006cited by this paper
• Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.

  2006cited by this paper
• Biological Transmission of Arboviruses: Reexamination of and New Insights into Components, Mechanisms, and Unique Traits as Well as Their Evolutionary Trends

  2005cited by this paper
• CODEHOP-mediated PCR – A powerful technique for the identification and characterization of viral genomes

  2005cited by this paper
• Protein response of insect cells to bioreactor environmental stresses.

  2005cited by this paper
• Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus

  2005cited by this paper
• Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

  2005cited by this paper
• Consensus-degenerate hybrid oligonucleotide primers (CODEHOP) for the detection of novel papillomaviruses and their application to esophageal and tonsillar carcinomas.

  2005cited by this paper
• Production of a Recombinant Influenza Vaccine Using the Baculovirus Expression Vector System

  2003cited by this paper
• Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2002cited by this paper
• Early detection of endogenous retroviruses in chemically induced mouse cells.

  2001cited by this paper
• BMC Evolutionary Biology BioMed Central BMC 1 2001, Evolutionary Biology:3

  2001cited by this paper
• Pert analysis of endogenous retroviruses induced from K-BALB mouse cells treated with 5-iododeoxyuridine: a potential strategy for detection of inducible retroviruses from vaccine cell substrates.

  2001cited by this paper
• Pert analysis of endogenous retroviruses induced from K-BALB mouse cells treated with 5-iododeoxyuridine: a potential strategy for detection of inducible retroviruses from vaccine cell substrates.

  2001cited by this paper
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences.

  1998cited by this paper
• Analysis of risk to biomedical products developed from animal sources (with special emphasis on the spongiform encephalopathy agents, scrapie and BSE).

  1996cited by this paper
• Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly

  1996cited by this paper
• Susceptibility of the Sf9 insect cell line to infection with adventitious viruses.

  1994cited by this paper
• Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom.

  1994cited by this paper
• High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults

  1994cited by this paper
• Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody.

  1986cited by this paper
• Regulation of viral transcription in cells infected with iododeoxyuridine-substituted simian virus 40 as a model for the activation by iododeoxyuridine of latent viral genomes.

  1981cited by this paper
• Induction of Venezuelan equine encephalitis (Mucambo) virus by iododeoxyuridine in chronically infected 'cured' cultured mosquito cells.

  1977cited by this paper
• The establishment of two cell lines from the insectspodoptera frugiperda (lepidoptera; noctuidae)

  1977cited by this paper
• 5-iododeoxyuridine potentiation of the replication in vitro of several unrelated RNA and DNA viruses

  1975cited by this paper

• A continuous viral vaccine biomanufacturing platform utilizing multiple bioreactor configurations

  2026cites this paper
• Re-shaping the immune response to influenza vaccination in a host with immune memory from influenza infection.

  2026cites this paper
• Enhancing CRISPR Homology Directed Repair in IAL-PiD2 Insect Cells via Reagent Delivery Optimization and Cell Synchronization.

  2026cites this paper
• An mRNA influenza vaccine induces immunity comparable to an adjuvanted vaccine in a randomized trial

  2026cites this paper
• Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses

  2025cites this paper
• Hemagglutinin-displaying influenza nanovaccines: progress and promise.

  2025cites this paper
• Adaptability and resiliency of lepidoptera and their cells in culture - Linking evolutionary biology to biotechnological advantage.

  2025cites this paper
• Immunogenicity in mice and non-human primates of an Advax-CpG55.2-adjuvanted recombinant hemagglutinin seasonal quadrivalent influenza vaccine.

  2025cites this paper
• Evaluation of high-throughput sequencing for replacing the conventional adventitious virus detection assays used for biologics

  2025cites this paper
• Characterization of Endogenous Retroviral-like Particles Expressed from the Spodoptera frugiperda Sf9 Cell Line

  2025cites this paper
• Glycoproteomic and Single-Protein Glycomic Analyses Reveal Zwitterionic N-Glycans on Natural and Recombinant Proteins Derived From Insect Cells

  2025cites this paper
• Re-shaping the immune response to influenza vaccination in a host with immune memory from influenza

  2025cites this paper
• Systems immunology analysis of human immune organoids identifies host-specific correlates of protection to different influenza vaccines.

  2025cites this paper
• Guided design for the development of an evolution-proof influenza vaccine.

  2025cites this paper
• Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genes

  2025cites this paper
• Characterization of Goatpox virus major intracellular mature virion proteins A27L and P32 expressed by baculovirus system: Superior to Escherichia coli.

  2025cites this paper
• Purification and characterization of recombinant neuraminidase as a potentially broadly protective influenza virus vaccine candidate.

  2025cites this paper
• Production and compositional analysis of full-length influenza virus hemagglutinin in Nanodiscs: Insights from multi-angle light scattering.

  2024cites this paper
• Establishment & Characterization of a Non-Adherent Insect Cell Line for Cultivated Meat

  2024cites this paper
• A Recombinant Mosaic HAs Influenza Vaccine Elicits Broad-Spectrum Immune Response and Protection of Influenza a Viruses

  2024cites this paper
• Dual-Engineered Phage Vaccine Platform Facilitates STING Activation for Influenza Protection.

  2024cites this paper
• Production of Influenza Virus Glycoproteins Using Insect Cells.

  2024cites this paper
• Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies

  2024cites this paper
• Diverting organic waste from landfills via insect biomanufacturing using engineered black soldier flies (Hermetia illucens)

  2024cites this paper
• CHO cells for virus-like particle and subunit vaccine manufacturing.

  2024cites this paper
• Transcriptome‐based analysis of the molecular mechanism of recombinant protein expression in Periplaneta americana cells

  2024cites this paper
• Characterization of Sf9 cell clones with differential susceptibilities to Sf-rhabdovirus X+3.7 and Sf-rhabdovirus X- replication.

  2024cites this paper
• Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice

  2024cites this paper
• Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines

  2024cites this paper
• Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development

  2023cites this paper
• An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines

  2023cites this paper
• Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period

  2023cites this paper
• Influenza vaccine: a review on current scenario and future prospects

  2023cites this paper
• An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection.

  2023cites this paper
• An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice.

  2023cites this paper
• ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines

  2023cites this paper
• Quantitative proteomic analysis of extracellular vesicles in response to baculovirus infection of a Trichoplusia ni cell line

  2023cites this paper
• Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo

  2023cites this paper
• The effect of lipid composition on the thermal stability of nanodiscs.

  2023cites this paper
• Transcriptome analysis of Sf9 insect cells during production of recombinant Adeno‐associated virus

  2022cites this paper
• Strategies for Glycoengineering Therapeutic Proteins

  2022cites this paper
• A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants

  2022cites this paper
• Fast Tracking—Vaccine Safety, Efficacy, and Lessons Learned: A Narrative Review

  2022influential citation
• Innate and adaptive immune responses against Influenza A Virus: Immune evasion and vaccination strategies.

  2022cites this paper
• Summary of the National Advisory Committee on Immunization (NACI) Supplemental Statement on Recombinant Influenza Vaccines.

  2022cites this paper
• ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses

  2022cites this paper
• The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing

  2022cites this paper
• Factors influencing the immunogenicity of influenza vaccines

  2021cites this paper
• Comprehensive N‐glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells

  2021cites this paper
• Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan Parasites.

  2021cites this paper
• COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform

  2021cites this paper
• VLP‐factory™ and ADDomer©: Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display

  2021cites this paper
• SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

  2021cites this paper
• Seasonal influenza vaccination coverage and its association with COVID-19 in Saudi Arabia

  2021cites this paper
• International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety

  2021cites this paper
• An Overview of Influenza Viruses and Vaccines

  2021cites this paper
• Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies

  2021cites this paper
• Approaches in broadening the neutralizing antibody response of the influenza vaccine

  2021cites this paper
• Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome

  2021cites this paper
• Influenza

  2021cites this paper
• Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration

  2021cites this paper
• Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.

  2021cites this paper
• Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs

  2020cites this paper
• A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.

  2020cites this paper
• Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans

  2020cites this paper
• Challenges of Making Effective Influenza Vaccines.

  2020cites this paper
• Impact of Protein Glycosylation on the Design of Viral Vaccines.

  2020cites this paper
• Influenza forensics

  2020cites this paper
• Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics

  2020cites this paper
• A novel lamprey antibody sequence to multimerize and increase the immunogenicity of recombinant viral and bacterial vaccine antigens.

  2020cites this paper
• Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure–function relationships

  2020cites this paper
• Chemically Defined, High-Density Insect Cell-Based Expression System for Scalable AAV Vector Production

  2020cites this paper
• Heterologous viral protein interactions within licensed seasonal influenza virus vaccines

  2020cites this paper
• Immunopathogenesis, Immunization, and Treatment of Infectious Diseases

  2019cites this paper
• Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study

  2019cites this paper
• Production of porcine parvovirus virus-like particles using silkworm larvae

  2019cites this paper
• High-Throughput Production of Influenza Virus-Like Particle (VLP) Array by Using VLP-factory™, a MultiBac Baculoviral Genome Customized for Enveloped VLP Expression.

  2019cites this paper
• Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.

  2019cites this paper
• Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.

  2019cites this paper
• Advances in Biochemistry and Biotechnology Baculovirus : A Powerful Tool for Various Biotechnological Applications

  2019cites this paper
• Current and future influenza vaccines

  2019cites this paper
• Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies

  2019cites this paper
• Towards improved and broadly protective influenza vaccines

  2018cites this paper
• Comparative transcriptome analysis of a Trichoplusia ni cell line reveals distinct host responses to intracellular and secreted protein products expressed by recombinant baculoviruses.

  2018cites this paper
• The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics.

  2018cites this paper
• Titre : Title : Critical assessment of influenza VLP production in Sf 9 and HEK 293 expression systems Auteurs :

  2018cites this paper
• Towards improved and broadly protective influenza vaccines: Focus on delivery systems, routes of administration and animal models

  2018cites this paper
• A new approach for detecting adventitious viruses shows Sf-rhabdovirus-negative Sf-RVN cells are suitable for safe biologicals production

  2018cites this paper
• Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation.

  2018cites this paper
• Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan.

  2018cites this paper
• The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

  2018cites this paper
• Baculovirus-driven protein expression in insect cells: A benchmarking study.

  2018cites this paper
• A minimum fragment of polyhedrin for higher expression of foreign proteins in a baculovirus expression system

  2017cites this paper
• Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.

  2017cites this paper
• Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.

  2017cites this paper
• Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection

  2017cites this paper
• Process Optimization for Recombinant Protein Expression in Insect Cells

  2017cites this paper
• High-Yield Production Process of Influenza Virus-Like Particles in Human Cells Toward Large-Scale Vaccine Manufacturing

  2017cites this paper
• Whole-Genome Sequence of the Spodoptera frugiperda Sf9 Insect Cell Line

  2017cites this paper
• Infectivity of Sf-rhabdovirus variants in insect and mammalian cell lines.

  2017cites this paper